Zyprexa Failure-To-Warn Suit Survives In MDL

Law360, New York (August 7, 2009, 2:57 PM EDT) -- A federal judge has refused to throw out a woman's claims that Eli Lilly & Co.'s anti-psychotic Zyprexa caused her to develop diabetes, finding that a material issue of fact remains as to whether the company's alleged failure to warn of the drug's risks caused or worsened the condition.

In a July 28 ruling, Judge Jack Weinstein of the U.S. District Court for the Eastern District of New York shot down Lilly's bid to dismiss Venica Pruett's lawsuit, part of a massive multidistrict litigation concerning allegations...
To view the full article, register now.